BP
Bharati Patwari Rastogi
About Bharati Patwari Rastogi
Data last updated:
Bharati Patwari Rastogi is a Director at M.M. Remedies Private Limited (since 2018), Director at Das Drugs Private Limited (since 2022) and Director at Kant Drugs Private Limited (since 2021). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹187 Cr; the largest is M.M. Remedies Private Limited at ₹137 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 M.M. Remedies Private Limited U24231UP1998PTC023497 | Director | 20 Mar 2018 | 1998 | ₹137 Cr (FY 2025) | Active |
| Das Drugs Private Limited U51109UP1997PTC022083 | Director | 15 Nov 2022 | 1997 | ₹38.25 Cr (FY 2025) | Active |
| Kant Drugs Private Limited U24232UP2001PTC025855 | Director | 18 May 2021 | 2001 | ₹11.20 Cr (FY 2022) | Active |
Board colleagues of Bharati Patwari Rastogi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bharati Patwari Rastogi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bharati Patwari Rastogi
Bharati Patwari Rastogi currently holds 3 directorships: M.M. Remedies Private Limited (Director, since 20 Mar 2018, revenue ₹137 Cr (FY 2025)); Das Drugs Private Limited (Director, since 15 Nov 2022, revenue ₹38.25 Cr (FY 2025)); Kant Drugs Private Limited (Director, since 18 May 2021, revenue ₹11.20 Cr (FY 2022)).
Bharati Patwari Rastogi was first appointed on 20 Mar 2018 as Director at M.M. Remedies Private Limited. The most recent appointment on record is 15 Nov 2022 at Das Drugs Private Limited.
The 3 current companies of Bharati Patwari Rastogi that report revenue have a combined latest revenue of ₹187 Cr: M.M. Remedies Private Limited ₹137 Cr (FY 2025); Das Drugs Private Limited ₹38.25 Cr (FY 2025); Kant Drugs Private Limited ₹11.20 Cr (FY 2022).
The current boards of Bharati Patwari Rastogi's companies include Anupama Rastogi (M.M. Remedies Private Limited), Anurag Das (M.M. Remedies Private Limited), Ekta Rastogi (M.M. Remedies Private Limited), Manjulata Rastogi (M.M. Remedies Private Limited), Manoj Rastogi (M.M. Remedies Private Limited), Mehul Rastogi (M.M. Remedies Private Limited), among others.